AI Article Synopsis
- The study investigates the risks of stopping versus continuing anticoagulant and/or antiplatelet medications (ACAP) before cervical and thoracic epidural steroid injections, focusing on the incidence of epidural hematomas (EHs).
- Data from 591 patients scheduled for interlaminar cervical and/or thoracic epidural steroid injections between 2009 and 2017 was analyzed, revealing that 351 patients stopped their ACAP medications, while 240 continued them without any clinically relevant cases of EHs.
- The findings suggest that there is a minimal risk of EHs regardless of whether patients ceased or maintained their ACAP, prompting a re-evaluation of current practices regarding these medications before the
Article Abstract
Background: There is a lack of substantiated evidence to support or refute the risks of ceasing vs maintaining anticoagulant and/or antiplatelet medications (ACAP) prior to cervical and thoracic interlaminar epidural steroid injections. The ACAP medication is frequently stopped pre-procedure due to concerns for potential bleeding complications, particularly epidural hematomas (EH). This article provides evidence regarding EH incidence in this population.
Methods: Data for this study was collected retrospectively on all patients from September 19, 2009-Jun 16, 2017 who were scheduled for an Interlaminar Cervical and/or Thoracic Epidural Steroid Injections (IL-CTESI) and were on an ACAP medication at the time a procedure was scheduled. All possible adverse outcomes were then retrospectively analyzed via extensive data mining of the electronic medical record system with special emphasis on EHs.
Results: 591 IL-CTESI were performed on patients taking ACAP medications. In total, 351 patients ceased their ACAP medication prior to the procedure and 240 maintained ACAP medication. Our findings demonstrate that there were no clinically relevant incidents of EHs in either cohort.
Conclusions: This data gives critical insight into the post-procedural EH risk for patients who had continued or stopped taking their ACAP medications prior to their IL-CTESI. The results from this study suggest re-evaluating the potential post-procedural EH risks associated with continuing vs ceasing these medications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372954 | PMC |
| http://dx.doi.org/10.1016/j.inpm.2023.100277 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spatiotemporal distribution in chemical composition of wet atmospheric deposition in Bandung Indonesia.
Environ Sci Pollut Res Int
November 2024
Research Center for Climate and Atmosphere, National Research and Innovation Agency, Jl. Sangkuriang, Dago, Bandung, 40135, Indonesia.
Article Synopsis
- Bandung, Indonesia, demonstrates the relationship between climate variability and topography affecting wet deposition, with a focus on pH levels and pollutants as part of the Acid Deposition Monitoring Network.
- The study found that specific ions varied in distribution due to local emissions, while high-traffic areas were more acidic compared to rural sites, which had a basic pH due to different ion concentrations.
- Seasonal patterns showed higher total ion concentrations during dry seasons, influenced by climatic events like El Niño/La Niña, and indicated ongoing changes in emission sources and environmental conditions.
FACTFINDERS FOR PATIENT SAFETY: Minimizing risks with cervical epidural injections.
Interv Pain Med
September 2024
Jordan Young Institute, Virginia Beach, VA, USA.
This series of FactFinders presents a brief summary of the evidence and outlines recommendations to minimize risks associated with cervical epidural injections. Evidence in support of the following facts is presented. - 1) CILESIs should be performed at C6-C7 or below, with C7-T1 as the preferred access point due to the more generous dorsal epidural space at this level compared to the more cephalad interlaminar segments.
View Article and Find Full Text PDFEpidural hematoma risks associated with ceasing vs maintaining anticoagulant and/or antiplatelet medications for cervical and thoracic interlaminar epidural steroid injections.
Interv Pain Med
September 2023
Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, 2201 Children's Way Suite 1318, Nashville, TN, 37212, USA.
Article Synopsis
- The study investigates the risks of stopping versus continuing anticoagulant and/or antiplatelet medications (ACAP) before cervical and thoracic epidural steroid injections, focusing on the incidence of epidural hematomas (EHs).
- Data from 591 patients scheduled for interlaminar cervical and/or thoracic epidural steroid injections between 2009 and 2017 was analyzed, revealing that 351 patients stopped their ACAP medications, while 240 continued them without any clinically relevant cases of EHs.
- The findings suggest that there is a minimal risk of EHs regardless of whether patients ceased or maintained their ACAP, prompting a re-evaluation of current practices regarding these medications before the
The Effect of Anticoagulant and Antiplatelet Medications on Wide-Awake Hand Surgery: An Analysis of 2,162 Cases.
J Hand Surg Am
October 2024
Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA; Orthopaedics Department, Drexel University College of Medicine, Philadelphia, PA. Electronic address:
Purpose: The purpose of the study was to determine if perioperative prescription anticoagulant (AC) or antiplatelet (AP) medication use increases the rate of revision surgeries or complications following wide-awake hand surgery performed under local anesthesia.
Methods: All patients who underwent outpatient wide-awake hand surgery under local anesthesia without a tourniquet by two fellowship-trained orthopedic hand surgeons at a single academic practice over a 3-year period were included. Prescription history was reviewed to determine if any prescriptions were filled for an AC/AP drug within 90 days of surgery.
The impact of different anticoagulants and antiplatelets regimens on acute epistaxis outcomes.
Eur Arch Otorhinolaryngol
September 2024
Department of Otolaryngology, Head and Neck Surgery, Kaplan Medical Center, Rehovot, Israel.
Background: The impact of anticoagulants (AC) and antiplatelets (AP) on the management of acute epistaxis remains unclear. This study investigated the association between AC/AP therapy and treatment outcomes in patients with acute epistaxis.
Methodology: A retrospective analysis of patients presented to the otolaryngology emergency room with acute epistaxis (2014-2022).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!